InvestorsHub Logo
icon url

illmatix0711

10/10/17 6:29 PM

#30430 RE: Samsa #30429

well i was was wondering about that too ...

someone posted sth about lower focalin sales in summer because of
summer holiday and stuff :)

i dont care the numbers are the numbers ...

but i can say that every short i was talking to expected an offering.

this is their position of strength here. at the end show me a bio with a marketcap of 35 mio and this pipeline about to be cash pos ..

still a joke where we are trading at

good night :)
icon url

doogdilinger

10/10/17 7:32 PM

#30435 RE: Samsa #30429

Agreed Samsa...using all the reported Bloomberg numbers has proven to be a totally useless endeavor
icon url

wimuskyfisherman

10/10/17 7:39 PM

#30439 RE: Samsa #30429

Samsa- It makes total sense... Focalin numbers were down as exclusivity expired. Last Q was the Focalin revenue peak.

Now look at the MNK numbers. Take 10-20% of the profits... Now does it make sense. I think everyone expected 40-50% of the raw MNK Seroquel revenue number. That did not hold true.
icon url

wimike

10/10/17 7:40 PM

#30440 RE: Samsa #30429

Revenues make no sense unless our % share with MNK is a lot lower than what many thought it would be. Very disappointing.